The prestigious PharmaTimes Marketer of the Year competition closes for entries and nominations in just 11 days. Spaces are filling up fast, so If you are thinking of entering, don't hesitate any longer - take advantage of this great opportunity and submit your entry now!
The US Food and Drug Administration has approved Pfizer’s Besponsa, the first and only CD22-directed antibody-drug conjugate indicated to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).
The Department of Health has announced £5 million of funding for a new obesity policy research unit at University College London, alongside plans to cut calories in some foods to reign in the rising trend of childhood obesity.
Cancer Research UK and Newcastle University have extended their strategic drug discovery alliance with Astex Pharmaceuticals by three years to work on developing new cancer drugs and associated biomarkers.
Public Health England and the Royal College of Nursing are urging new university students to get vaccinated against meningitis so that they can build immunity to the disease before fresher’s week, after figures show that uptake of the jab last year was low.